We are live on
!
Find out more
AGP
Aspire Growth Partners Portfolio holdings
AUM
$172M
1-Year Est. Return
33.61%
This Fund
S&P 500
This Quarter
Est. Return
+9.56%
1 Year Est. Return
+33.61%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$122M
AUM Growth
+$9.35M
(+8.3%)
Cap. Flow
-$42.6K
Cap. Flow
% of AUM
-0.03%
Top 10 Holdings %
Top 10 Hldgs %
47.09%
Holding
117
New
4
Increased
32
Reduced
68
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$715K |
| 2 |
Capital Group Core Equity ETF
CGUS
|
+$596K |
| 3 |
GE Vernova
GEV
|
+$492K |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$437K |
| 5 |
Capital Group Core Plus Income ETF
CGCP
|
+$349K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Equal Weighted ETF
EUSA
|
+$526K |
| 2 |
Vanguard S&P 500 Growth ETF
VOOG
|
+$420K |
| 3 |
L3Harris
LHX
|
+$404K |
| 4 |
Broadcom
AVGO
|
+$331K |
| 5 |
Mastercard
MA
|
+$298K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.86% |
| 2 | Financials | 6.07% |
| 3 | Industrials | 5.75% |
| 4 | Healthcare | 5.58% |
| 5 | Consumer Discretionary | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Edwards Lifesciences
EW
$50B
| $243K | 0.2% |
3,107
-64
| -2% | -$4.77K |
|
|
102
L3Harris
LHX
$50.7B
| $243K | 0.2% |
967
-1,760
| -65% | -$404K |
|
103
BP
BP
$114B
| $235K | 0.19% |
7,856
-99
| -1% | -$2.9K |
|
104
CytomX Therapeutics
CTMX
$714M
| $232K | 0.19% |
102,254
+10,000
| +11% | +$16.1K |
|
105
Amplify CWP Enhanced Dividend Income ETF
DIVO
$7.51B
| $228K | 0.19% |
5,364
+44
| +0.8% | +$1.79K |
|
106
Stryker
SYK
$133B
| $228K | 0.19% |
577
-100
| -15% | -$37.4K |
|
107
Qualcomm
QCOM
$160B
| $220K | 0.18% |
1,379
-28
| -2% | -$4.12K |
|
108
NextEra Energy
NEE
$183B
| $219K | 0.18% |
3,151
+8
| +0.3% | +$556 |
|
109
Chipotle Mexican Grill
CMG
$49.4B
| $217K | 0.18% |
3,863
-34
| -0.9% | -$1.73K |
|
110
S&P Global
SPGI
$122B
| $217K | 0.18% |
411
-104
| -20% | -$51.9K |
|
111
Gilead Sciences
GILD
$163B
| $212K | 0.17% |
+1,910
| New | +$203K |
|
112
Howmet Aerospace
HWM
$111B
| $206K | 0.17% |
1,109
-245
| -18% | -$37.7K |
|
113
Cigna
CI
$76.1B
| $206K | 0.17% |
624
-131
| -17% | -$42.2K |
|
114
Nuveen Preferred & Income Opportunities Fund
JPC
$2.88B
| $95.2K | 0.08% |
11,872
+99
| +0.8% | +$768 |
|
115
AutoZone
AZO
$49.1B
| – | – |
-62
| Closed | -$232K |
|
|
116
Mastercard
MA
$510B
| – | – |
-527
| Closed | -$298K |
|
117
Progressive
PGR
$124B
| – | – |
-758
| Closed | -$217K |
|
Similar funds
BIA
CRFG
SPF
TA
AIG
GWCM
AIM
BAM
Aspire Growth Partners's Q2 2025 Portfolio in Review
As of Q2 2025, Aspire Growth Partners held 117 positions worth $122M, up 8.3% from $113M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Aspire Growth Partners's Q2 2025 filing shows 4 new, 32 increased, 68 reduced and 3 closed positions. Its largest new stake was GE Vernova: 1,181 shares worth $625K. The largest sale was iShares MSCI USA Equal Weighted ETF, an estimated $526K.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.
- Aspire Growth Partners's largest Q2 2025 buy was GE Vernova: 1,181 shares worth $625K.
- Aspire Growth Partners added most to Apple in Q2 2025, an estimated $715K increase.
- Aspire Growth Partners's biggest Q2 2025 reduction was iShares MSCI USA Equal Weighted ETF, cutting an estimated $526K.
- Aspire Growth Partners fully exited Mastercard in Q2 2025, selling an estimated $298K.
- Aspire Growth Partners's ten largest holdings make up 47% of its $122M portfolio in Q2 2025.
- Aspire Growth Partners opened 4 new positions and closed 3 in Q2 2025.
- Aspire Growth Partners's portfolio value rose 8.3% quarter-over-quarter to $122M.
Based on Aspire Growth Partners's 13F filing for Q2 2025, filed 13 Aug 2025.